Skip to content
Sharism- Lifestyle
Author:
VolitionRx Limited
VolitionRx Limited Announces Third Quarter 2026 Financial Results and Business Update
November 12, 2026
VolitionRx Limited Schedules Third Quarter 2026 Earnings Conference Call and Business Update
November 9, 2026
VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition’s Lateral Flow Technology for NETosis Worldwide
October 27, 2026
VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash
October 27, 2026
VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
September 17, 2026
VolitionRx Participates in Launch of DETECSEPS Program in France
September 17, 2026
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
September 14, 2026
Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference
September 10, 2026
Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
August 12, 2026
Volition Advances Nu.Q® NETs Platform Towards Commercialization
July 30, 2026
1
2
Next Page
→